Thank you for requesting Know Your Rare Disease Market.
To download a copy of this document, please provide the following basic information:In recent years, rare disease products have become an attractive area for pharmaceutical and biotech development. They tend to have shorter or accelerated clinical development timelines, lower development and commercialization costs, fewer life-cycle challenges, and increased deal activity. While the average revenue from a product with a rare disease indication may be lower compared with the more traditional therapeutic areas, rare diseases still present a lucrative opportunity and the space has become a focus for many companies in today’s competitive drug market. As a company begins to evaluate the requirements for successful development and commercialization of a rare disease drug, the company will need to be cognizant of the unique aspects of the rare disease market and how these will drive the commercialization process.